Medicines save lives but they can be costly and can have serious adverse effects. Value-laden decisions are continuously being made at individual, institutional, national and international levels regarding the medicines we need, want and can afford. In this unit of study, we will explore and critique global and national policies and processes related to medicines, examining how research and development agendas are set; how medicines are assessed and evaluated; and how new technologies are translated into practice. We will also explore broader trends such as globalisation, commercialisation and changing consumer expectations. By the end of the course, students will understand the forces shaping the development, regulation, funding and uptake of medicines both nationally and internationally, and the political, ethical, legal and economic issues that are at stake. This course is designed to appeal to a wide range of students from ethics, law, public health, health care, policy, communications, economics, business, politics, administration, and biomedical science.
Unit details and rules
Academic unit | Public Health |
---|---|
Credit points | 6 |
Prerequisites
?
|
None |
Corequisites
?
|
None |
Prohibitions
?
|
None |
Assumed knowledge
?
|
A degree in science, medicine, pharmacy, nursing, allied health, philosophy/ethics, sociology/anthropology, history, law, communications, public policy, business, economics, commerce, organisation studies, or other relevant field, or by special permission |
Available to study abroad and exchange students | No |
Teaching staff
Coordinator | Anson Fehross, anson.fehross@sydney.edu.au |
---|---|
Lecturer(s) | Anson Fehross, anson.fehross@sydney.edu.au |